Literature DB >> 9615795

Alkaline phosphatase isoenzymes in detection and follow up of breast cancer metastases.

C Ritzke1, P Stieber, M Untch, D Nagel, W Eiermann, A Fateh-Moghadam.   

Abstract

Alkaline phosphatase isoenzymes in bone and liver metastases of breast cancer were determined in 637 patients and during follow up in 116 patients, by agarose gel electrophoresis. The activity of total alkaline phosphatase, gamma glutamyl transferase, CEA and CA 15-3 was also determined. The sensitivity of bone alkaline phosphatase in bone metastases detection was 39%, of electrophoresis (total alkaline phosphatase and specific isoenzymes) 48% and of enzymes and tumor markers together 85% (n = 62). For liver metastases gamma glutamyl transferase had the best sensitivity (100%, n = 19). Even though positive predictive value was only 6%, the sensitivity of liver alkaline phosphatase was 58% and of electrophoresis 94%. The determination of alkaline phosphatase isoenzymes is a non-invasive, in-expensive, reproductable and rapid method to detect progressive disease in breast cancer, especially in combination with the tumor markers CA 15-3 and CEA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9615795

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Case of an ivory vertebra.

Authors:  S Basaria; E F McCarthy; A J Belzberg; D W Ball
Journal:  J Endocrinol Invest       Date:  2000-09       Impact factor: 4.256

2.  Bone Metastasis Prognostic Factors in Breast Cancer.

Authors:  Akram Yazdani; Sara Dorri; Alirezza Atashi; Hoda Shirafkan; Hedieh Zabolinezhad
Journal:  Breast Cancer (Auckl)       Date:  2019-02-22

3.  Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer.

Authors:  Wen-Zhao Chen; Jun-Feng Shen; Yang Zhou; Xuan-Yin Chen; Jia-Ming Liu; Zhi-Li Liu
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.